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Many patients with axial spondylarthritis (axSpA) experience lengthy diagnostic delays
upwards of 14 years. (5–14 years). Screening tools for axSpA have been proposed for use
in primary care settings, but whether this approach could be implemented into busy primary
care settings remains unknown.
Objective
To solicit feedback from primary care physicians regarding questions from the Inflammatory
Back Pain Assessment: the Assessment of Spondyloarthritis International Society (ASAS)
Expert Criteria and gain insight about barriers and facilitators for implementing axSpA
screening in primary care.
Methods
Guided by Consolidated Criteria for reporting Qualitative Research (COREQ-criteria), we
recorded, transcribed, and analyzed in-depth interviews with eight family medicine physi-
cians and ten internists (purposeful sampling) using immersion/crystallization techniques.
Results
Few physicians reported awareness of existing classification criteria for axSpA, and many
reported a lack of confidence in their ability to distinguish between inflammatory and
mechanical back pain. From three domains, 10 subthemes emerged: 1) typical work-up of
axSpA patients in primary care, with subthemes including the clues involved in work-up and
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role of clinical examinations for axSpA; 2) feedback on questions from the Inflammatory
Back Pain Assessment: ASAS Expert Criteria, with subthemes to evaluate contents/ques-
tions of a potential screening tool for axSpA; and 3) implementation of the screening tool in
primary care settings, with subthemes of perceived barriers including awareness, time,
other conditions to screen, rare disease, and lack of structured questionnaire for back pain
and perceived facilitators including workflow issues and awareness.
Conclusions
Primary care physicians believed that an improved screening instrument and a strong evi-
dence-base to support the need for screening for axSpA are required. The implementation
of axSpA screening into a busy primary care practice requires integration into the practice
workflow, with use of technology suggested as a possible way to improve efficiency.
Introduction
Axial spondyloarthritis (axSpA) is an inflammatory disease characterized by chronic back pain
[1]. Prevalence estimates vary widely [2]. In the US, ~1% of the adult population is estimated
to have axSpA [3], whereas in Canada the prevalence has been estimated to be 213 per 100,000
[4]. The diagnostic journey experienced by patients with axSpA is often lengthy, lasting
upwards of 14 years in the United States [5–7], and delayed diagnosis can result in greater
functional impairment, higher healthcare costs, and worse quality of life [8]. Early initiation of
treatment can reduce symptoms [9], and may delay disease progression [9] and prevent dis-
ability [10].
Primary care providers have described reasons for delayed diagnosis of axSpA including
disease characteristics (e.g., back pain is common, whereas axSpA is relatively uncommon);
patient perception (e.g., sharing back pain at end of appointment); provider unfamiliarity (e.g.,
lack of awareness about axSpA); and healthcare system-related issues (e.g., brevity of primary
care appointments) [11]. Although rheumatologists play a pivotal role in caring for patients
with axSpA, most patients often consult with primary care providers (e.g., primary care physi-
cians or internalist) seeking symptom relief when they initially have their symptoms (i.e., back
pain or spinal pain) and are diagnosed by primary care providers other than rheumatologists
[5]. Several sets of classification criteria exist for axSpA, including the modified New York cri-
teria [12], the Berlin criteria [13], the Amor tool [14], the European Spondylarthropathy Study
Group (ESSG) criteria [15], and the Assessment of Spondyloarthritis International Society
(ASAS) criteria [16]. Yet, it is not known whether healthcare providers, other than those in
rheumatology, are familiar with these criteria [17].
Several approaches to assist in identifying patients with axSpA have been explored in pri-
mary care settings, including the use of screening questionnaires [18, 19], early referral tools
that combine clinical criteria and laboratory and imaging test results [20], and automated
referral algorithms using electronic medical record (EMR) data [21]. However, few studies [22,
23] have engaged primary care providers to gather their opinions about screening tools for
axSpA in clinical practice.
As part of a larger qualitative research study [SpodyloArthritis Screening and Early Detec-
tion (SpA-SED) Study], the primary objective of this study was to evaluate primary care physi-
cian perspectives and views about the use of a screening tool for axSpA. This analysis focuses
on statements made by primary care physicians regarding their baseline practices on typical
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work-up of axSpA patients, feedback on questions from the Inflammatory Back Pain Assess-
ment: the Assessment of Spondyloarthritis International Society (ASAS) Expert Criteria [19],
and barriers and facilitators for implementation of axSpA screening in the primary care set-
ting. The results of this study will provide foundational knowledge for the development and
implementation of screening tools for axSpA.
Materials and methods
The University of Massachusetts Medical School Institutional Review Board approved this
study. All participants provided written informed consent.
Study sample and setting
We recruited 18 primary care physicians to achieve saturation, with gender (8 women) and
specialty balance (8 Family Medicine and 10 Internal Medicine) from January to May 2019. To
be eligible, a physician must be a primary care physician in clinical practice and were able and
willing to participate in an interview. Physicians were ineligible if they were: 1) unable to par-
ticipate in a discussion lasting no more than 60 minutes; 2) unwilling to be audio recorded; 3)
unable to consent; and 4) non-English-speaking subjects. Using purposeful sampling, we
reached out to primary care physicians in Massachusetts and Rhode Island who were known
to the authors and to regional professional societies (e.g., Rhode Island Academy of Family
Physicians) to identify potential participants [24]. We identified 34 potential participants and
completed 18 60-minute, audio-recorded interviews (3 in person, 15 on the phone, conducted
by either KL, DS with SL or DS taking notes, no other people were present). No repeat inter-
views were conducted. One participant had conducted research (unrelated to axSpA) with the
interviewer >5 years previously. Participants were compensated for their time with a $300
cash card.
Study protocol
A multidisciplinary team developed the interview protocol guided by the consolidated criteria
for reporting of qualitative research (COREQ) [25] and informed by a literature review and
insights from the research team, which included two rheumatologists (S1 Table). We collected
the qualitative data using in-depth interviews with a semi-structured interview outline. Each
interview was conducted on a one-to-one basis with an observer from the research team taking
notes. We began the interview with physicians’ baseline practices on typical work-up of axSpA
patients. We then solicited feedback during a question-by-question review of the Inflamma-
tory Back Pain Assessment: ASAS Expert Criteria to understand their perspectives on those
questions to screen axSpA patients [19]. The interviews were then completed by asking ques-
tions about implementation of axSpA screening tools in primary care settings. To understand
the characteristics of physician participants in the study, we lastly administered a structured
questionnaire at the end of interviews. It included items about socio-demographics, practice
characteristics, awareness of the features of inflammatory back pain according to several differ-
ent sets of classification criteria (i.e., Calin [26], Berlin [27], and ASAS [19]) and “any other cri-
teria” (open-ended), and the following question: “How confident are you in distinguishing
inflammatory back pain from mechanical back pain?” (extremely, very, somewhat, or not con-
fident). Interviewers were members from the research team who had experience with in-depth
interview and trained in qualitative research as well as for this study protocol. We also con-
ducted pilot testing of the interview protocol with a primary care physician not participating
in the study and did not include the data in this analysis. Interviewers reported no explicit bias
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related to the topic under study but believed that primary care physicians may lack awareness
about axSpA.
Qualitative data analysis
We recorded each in-depth interview and discussion with the participants. We used a content
analysis approach to completely transcribe and code the data collected. Transcription was car-
ried out verbatim. We did not ask participants to review the transcripts of their interviews for
comment or correction. We developed a hierarchical coding structure and handbook based on
review of the first few transcripts and expanded throughout data analysis. Two research assis-
tants performed line-by-line coding of the transcripts with NViVo qualitative software. Quali-
tative review of the dual coding confirmed that passages often appeared twice, suggestive of
effective coding. The data were analyzed as a group using immersion / crystallization tech-
niques [28]. We requested feedback from participants wiling to review results. This manuscript
focuses on three themes in our coding structure: 1) baseline practices on typical work-up of
axSpA patients; 2) feedback on the Inflammatory Back Pain Assessment: ASAS Expert Criteria
questions; and 3) perspectives and views about implementation of axSpA screening tools in
primary care settings.
Results
On average, the study participants had been practicing in the field for a mean of 15.7 (±13.0)
years (Standard Deviation) (Table 1). Most physicians were Non-Hispanic White, trained at
US allopathic schools, and were affiliated with academic institutions. No family medicine phy-
sicians and only 30% of internal medicine physicians had heard of the ASAS classification cri-
teria. No internists and 2 of 8 family medicine doctors reported feeling “extremely confident”
and 3 of 8 family medicine and 3 of 10 of internists reported that they felt “very confident” in
distinguishing inflammatory back pain from mechanical back pain.
In line with the interview protocols, 3 main themes along with 10 subthemes were estab-
lished (Table 2).
Typical baseline work-up of axSpA patients
When asking of the typical baseline work-up of axSpA patients (Table 3), physicians noted sev-
eral clinical observations potentially pointing to axSpA, including: 1) young people presenting
with back symptoms without any antecedent injury; 2) the presence of comorbid autoimmune
conditions; 3) peripheral joint involvement, and other systemic manifestations (e.g., iritis).
When speaking of the role of clinical examinations and tests, most physicians stressed that a
thorough medical history would be essential for diagnosing axSpA. Some also expressed con-
cern about having dissatisfied patients when costly tests are performed that may not yield
definitive results.
Feedback on questions from the Inflammatory Back Pain Assessment:
ASAS Expert Criteria
With respect to questions in ASAS Expert Criteria to screen patients with AxSpA (Table 4),
physicians were concerned that some questions were not specific (e.g., Have you suffered from
back pain for more than 3 months?) or sensitive (e.g., Did your back pain develop gradually?).
They were also concerned that patients with intermittent back pain might be missed. Physi-
cians suggested including questions about decreased range of motion or stiffness, heel pain
and other symptoms of enthesitis, psoriasis, and Crohn’s disease. Most did not like the
PLOS ONE Axial spondyloarthritis screening in primary care
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Table 2. Developed main themes and subthemes.
Main themes Subthemes
Typical baseline work-up of axSpA patients in primary care Clues in working up patients
Role of clinical examinations for axSpA
The Inflammatory Back Pain Assessment: the Assessment of
Spondyloarthritis International Society (ASAS) Expert Criteria
Contents/questions for a potential
screening tool for axSpA
Implementation of the screening tool in primary care settings Perceived barriers:
• Awareness
• Time
• Other conditions to screen
• Rare disease











Age (years), mean (SD) 52.9 (10.3) 42.0 (12.7)
Women, % 50.0 40.0
Race/ethnicity, %
Non-Hispanic, White 87.5 50.0




US Allopathic school 75.0 90.0
US Osteopathic school 0 0
Foreign medical school 25.0 10.0
Years in practice, mean (SD) 20.1 (13.4) 12.6 (12.3)
Practice characteristics: (check all that apply), %
Individual 0 0
� 5 physicians 25.0 30.0
�6 physicians 62.5 50.0
Hospital-based practice 25.0 50.0
Academic affiliation 62.5 70.0
Confidence in distinguishing inflammatory versus mechanical
back pain, %
Not confident 12.5 20.0
Somewhat confident 25.0 50.0
Very confident 37.5 30.0
Extremely confident 25.0 0.0
Knowledge of inflammatory back pain classification criteria, %
Calin criteria 0 0
Assessment of Spondyloarthritis International Society criteria 0 30.0
Berlin criteria 0 0
SD = Standard deviation; Percentages may exceed 100% due to rounding.
a For questions where respondents could select more than one answer choice, percentages may exceed 100%.
https://doi.org/10.1371/journal.pone.0252018.t001
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suggestion to immediately refer patients with 4 or 5 affirmative answers to a rheumatologist
because of concerns about the shortage of rheumatologists; however, they thought that it
would be helpful for specific tests to be suggested as next steps to pursue in evaluating these
patients.
Implementation of the screening tool in primary care settings
Physicians considered axSpA to be “uncommon” and perceived this as a barrier to implemen-
tation of a screening tool (Table 5). They suggested using such an instrument only in specific
clinics (e.g., pain clinics), if a patient presented with recurrent back pain, or before ordering
“expensive” tests. All physicians discussed lack of time as a barrier and pointed out that there
are many other common conditions for which they need to screen. A few indicated that they
would never use such a screening tool.
Table 6 summarizes primary care physicians’ perceptions of facilitators to implementation
of a screening tool for axial spondyloarthritis in primary care. Physicians expressed concern
that patients using an online screening tool might request unnecessary referrals. Suggestions
included administering the screening tool in the waiting room or by telephone before the visit,
during the appointment when axSpA is suspected, or by using a clickable link in the EMR
(Table 6). Physicians also suggested using machine learning to trigger when to initiate screen-
ing, embedding a screening tool in UpToDate (an online resource designed to provide physi-
cians access to current clinical information), and using smart phrases in EMR software to
record responses to the screening tool. Physicians want evidence to support the use of an
axSpA screening tool in practice (e.g., sensitivity and specificity; US Preventive Services Task
Force endorsement).
Discussion
In our study, many primary care physicians lacked awareness of classification criteria for
axSpA and most were not “extremely confident” in their ability to distinguish inflammatory
Table 3. Synthesis of physician work-up of axial spondyloarthritis.
Subthemes Synthesis Representative quotes
Clues in working up
pointing to axSpA
• Young age without any antecedent injury
• Comorbid conditions (e.g., psoriasis, Crohn’s, other
autoimmune conditions)
• Joint involvement in addition to back pain and other systemic
involvement (e.g., eye conditions, peripheral joint involvement,
“oddly shaped” digits)
• Decreased range of motion
• D17: The x-ray was suggestive, but I think it was also like a younger
person without any, like, real good reason to have back pain. No, like,
sports history, like, trauma or, you know, anything to really set it off.
• D12: If I’m getting that kind of positive history, I would probably go
deeper to rule out other associated conditions, like uveitis, other joint
pains, like in their hip, knees. ’Cause AS may have an SI joint problem,
so they may say my—you know, my butt hurts and something. They may
have all these digits maybe oddly shaped.
• D10: Certainly if they have a known condition like psoriasis or they
could have psoriatic arthritis or rheumatoid arthritis or any other
autoimmune kind of disease. If they’re hunched over, you know, we’d




• Physicians stressed that a thorough medical history was
essential to diagnosing axSpA
• Some physicians noted the importance of asking about family
history
• Conducting a good physical examination is important. Are they
hunched over? Can they bend over and touch toes?
• Physicians reported ordering the following images and lab tests:
• Plain X-rays, MRI (to look for bamboo spine)
• C-reactive protein, ESR, ANA, HLA-B27
• D17:Well, I think it’s important to take a good history. Because I think
you’re more likely to pick up on the symptoms suggestive of it with a
thorough history and the family history as well.
• D5: There’s actually a test where you can try to bend them over and
measure the distance between standing between four vertebrae standing
and flexing. So, most people can flex but if—ankylosing spondylitis, if it’s
all fused, you won’t be able to do that. And so—anyway, so sometimes
you can tell by physical exam.
• D23: imaging will show you—often they say, like, in the x-rays, it’s like
bamboo, it looks like bamboo along the spine. And so typically if I were
to do imaging that’s more what I would see.
https://doi.org/10.1371/journal.pone.0252018.t003
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Table 4. Synthesis of feedback from primary care physicians on Assessment of Spondyloarthritis International Society screening questions.
Question Major comments Representative quotes
Have you suffered from back
pain for more than 3 months?
• Thought it was a reasonable question because mechanical
back pain typically gets better in 6 weeks
• Thought the question lacked specificity
• Recognized that patients may experience flare-ups or
intermittent pain and misinterpret the question
• D32: Yeah, I think that’s in general we’re taught six to 12 weeks is
kind of what people should get, kind of between that acute and
more chronic phase, so I think three months is an appropriate time.
• D7: One is the lack of specificity in the question, you know,
because there’s some people who, you know, will say I’ve had back
pain for ten years and that means it’s come and gone. And so
whether that’s a follow-up question or whether you put in the
preface, you know, continued back pain or chronic back pain or
back pain that hasn’t gone away for the last three months.
Did your back pain start when
you were aged 40 or under?
• Agreed that age is clinically relevant
• Thought that this question would be easy for patients to
understand and answer
• Others thought that the question was “non-specific”, “too
broad”, and “sensitive not specific”
• Questioned the value of this information because many
people experience back pain under the age of 40 years and
there are other contributors to pain (e.g., overweight)
• D31: So, I do like the one about under the age of 40 because I
think that really fulfills the criteria that we often see with
inflammatory spondyloarthropathies
• D25: It’s a mix. I mean, the reason being—does that mean you
had an episode of low back pain before you were 40? Well, 80% of
the population has it during their lifetime and quite—you know, an
enormous number under the age of 40. So, it’s—I’d say it’s a not
particularly—it would—I would, you know, let’s see, I don’t know
the properties of the test but it’s not very specific.
Did your back pain develop
gradually?
• Agreed this question likely distinguishes inflammatory back
pain from pain resulting from an injury
• Thought most patients would be able to answer (yes or no).
• Thought the question was not sensitive enough
• Concerned that patients may not know when the back pain
began, that patients would have recall bias, and that
“gradually” was too vague and would be open to different
interpretations
• Some suggested asking “Was there a specific incident you
remember that caused your back pain?” which would have
helped to bring to light an identifiable incident
• D32: I feel like that would be kind of a vague question, ’cause
people are—kind of have different thoughts of how long gradually
means. Like did it occur over a day, did it occur over a month, it’s
tough to say.
• D27: That makes sense, too, ’cause it distinguishes like an injury
and like a—you know, it would have been a sudden start if it was an
injury.
Does your back pain improve
with exercise?
• Agreed that with inflammatory issues, improvement with
exercise expected
• Expressed concern question was not sensitive or specific
• Did not like the term “exercise” as they felt the term was
generic and vague. Not all patients “exercise” (because
“exercise is in the eye of the beholder”); could be interpreted
as “going to the gym”
• Concerned question may make patients feel “guilty and bad”
• Suggested alternative wording: “activity” or “move around”
• D34:’Cause exercise connotates I go to the gym and put on gym
shorts and I pump iron. That’s how I might have—that’s what I
think people might perceive, and it makes them feel guilty and bad,
when you ask, "Do you exercise?" and they say, "No." They’re
reluctant to answer that. "Are you physically active?" "Yeah, I love
going outdoors and playing with the kids, and we bike around." I
get a lot more out of, "Are you physically active," versus, "Do you
exercise?" I actually don’t like the word "exercise."
Do you find there is no
improvement in your back pain
when you rest?
• Thought the question was good because it is something
doctors don’t think about
• Like that it gets at mechanisms of symptoms (e.g., stiffness”)
• Thought that the “double negative wording” may be difficult
for patients to answer
• Some thought this question could be combined with the
question on exercise
• Suggested rewording: “When you rest, does your back get
better?”
• D28: If they find there is no improvement in back when you rest,
okay, that’s something I haven’t thought about, so I guess would be
a good one.
• D29: It may make more sense, like, "Does your back pain improve
with rest?" Because that’s, like, not a negative question, right?
Do you suffer from back pain at
night which improves upon
getting up?
• Thought question could be answered easily by patients
• Addresses something doctors don’t think about
• Ruled out osteoarthritis and was associated with morning
stiffness
• Thought the question needed a more specific time frame:
“better after 30 minutes into your day”; “more in the
morning, better towards to evening”
• Thought the question was not specific or sensitive. They
thought that chronic low back pain can be attributed to many
things (e.g., disks when lying flat, bad mattress)
• D10: If that’s suggestive of inflammatory spondylitis then I guess
it’s a reasonable question but I have a number of patients who say
their back pain is worse first thing in the morning when they get up
out of bed because they have a bad mattress,
• D27: Maybe thinking about, like—you could think about, like,
worse when you first get up in the morning or better after 30
minutes into your day, something like that.
• D17: I think the last one is helpful, too, because it’s more of a, like,
morning stiffness.
https://doi.org/10.1371/journal.pone.0252018.t004
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from mechanical back pain. Many of the physicians interviewed emphasized the importance
of taking a good medical history. Primary care physicians indicated that they would value a
screening tool that provided guidance on appropriate tests to order prior to a referral, rather
than an immediate referral to a rheumatologist, because of the difficulty in obtaining a timely
rheumatology consultation appointment. Barriers believed to impede implementation of
screening for axSpA in primary care included lack of time (because other more common con-
ditions require screening) and lack of awareness about axSpA. All physicians interviewed
emphasized the importance of integrating any proposed screening strategy into their clinical
workflow.
Physicians are concerned about overuse of testing and low-value healthcare given that dis-
satisfied patients when costly tests are performed that may not yield definitive results [29]. Pri-
mary care physicians have difficulty discriminating inflammatory back pain from other kinds
of back pain and are often unaware of other SpA features that are important for the differential
diagnosis. Add to this fact that the radiological proof is sometimes a late feature of the disease
and the result is the diagnostic delay. As such, primary care providers in our study thought
that an axSpA screening tool may be helpful if it could make use of visit time and health care
Table 5. Primary care physician perceptions of perceived barriers to implement the screening tool for axial
spondyloarthritis.
Subtheme Representative quotes
Awareness D07: Awareness is probably the biggest thing. I’m not aware of guidelines for
screening, using a specific screening tool. If you don’t know that it exists and
it’s evidence-based, that’s probably the biggest.
Time D10: Time, time.. . . a primary care visit now involves . . .15 minutes or 30
minutes long and in those 15 minutes. . . we have to screen . . .for depression,
. . .physical abuse at home, do their vital signs, and if . . . blood pressure is
elevated, do it several times, get their medication list cleaned up, . . .
completely reconcile the outside information now coming in through health
information exchanges, talk to the patient, oh, by the way, examine them,
come up with a plan, and document it all.
D22: So, we have 20-minute patient encounters. Usually it takes five minutes
to room a patient, then my time with the patient is from ten to 15 minutes, at
the most, and then we have to go out and talk and do everything else, so time
is definitely a constraint. I wish I had 40 minutes visits with the patient, but
that’s not possible.
D23: Anything that takes extra time, primary care doctors do not have, and we
already have so many forms and like notes–. . . There’s just so much that’s
already expected of us as primary care doctors and so anything . . . that you
can . . .prepopulate into the note and it’s . . . yes or no questions,.. . . the easier
and more efficient the better and the more likely people will use it. If it’s
cumbersome, people are less likely to integrate it in.
Other conditions to screen D12: My clinic is not just a back clinic. There are so many other things.
D28: I have a patient with back pain, they usually have four other things and
then they say by the way, I have back pain. . . . it’s overwhelming to do all that
in 15 minutes. That’s what we have; 15 minutes.
Rare disease D07: . . . thinking about it. . . . thinking about these diagnoses is probably the
biggest barrier.
D25: Ankylosing spondylitis is rare and so . . .what we need public health
campaigns about are, . . .clean water, clean air, exercise, healthy diet, safe sex,
you know, birth control, domestic violence. . . .to have a public health
campaign about a rare disease is. . . if there’s something we can do about it
significantly and change the course of the disease then it’s kind of worthwhile
but for symptom control, probably not.
Lack of structured questionnaire
for back pain
D10: I don’t have like a structured questionnaire or a structured note template
for back pain.
https://doi.org/10.1371/journal.pone.0252018.t005
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resources more efficient. Pressure from national campaigns to reduce ordering of imaging
(e.g., Choosing Wisely [30]), patient concerns about the high costs of laboratory tests that are
not fully covered by insurance [31], and the workforce shortage in rheumatology [32] all
underscore the value of using screening tools to identify patients in need of appropriate addi-
tional testing and referral to evaluate for axSpA.
Given the brief amount of time available to spend with patients in primary care appoint-
ments [33], physicians reinforced the notion that implementation of an axSpA screening tool
must not require additional physician time. Because the prevalence of axSpA in the general
population is low, a screening approach would need to target patients with chronic back pain
and rely on patient to complete a questionnaire. Participants suggested working through the
Table 6. Primary care physician perceptions of perceived facilitators to implement the screening tool for axial spondyloarthritis.
Subtheme Key areas Representative quotes
Workflow
issues
Simple and less time-consuming D23: If there was a really easy website or smart phrase that I could get to, like . . .all the medical
records systems they have. It’s like Epic Care Connect, there are these things called smart phrases,
they’re like dot phrases. So if I were to say dot AS, . . .it would prepopulate all the, like, screening
questions I would need to ask.
Ease and efficiency/ maybe an app or
algorithm/ incorporated into an EMR
D23: I think the biggest thing in terms of getting people to screen more is doing something that is
very efficient and easy to implement.
D01: Maybe some sort of form for the patient or an app, something where they could fill out so that
. . . the questions would be completed before I start interviewing them and I could just review the
questions with them. . .
D31: doing something that would make it more facilitated to . . .incorporate the criteria into an
electronic medical record. I think that’s what will make like easier for everybody, where I wouldn’t
have to pull out my phone, where all I would do is . . .click something or click a pulldown menu and
say yes, yes, no, yes, you know, that kind of thing.
Use of templates and health information
technology
D07: I do think that the idea of how to integrate it, especially in busy primary care centers, is tough
. . .I’m not sure that I have the perfect idea because on the one hand if you’re just considering this
and just thinking about back pain, . . .I think it all makes perfect sense, but yet creating the perfect
template, . . .this is back pain, but then there’s five other things, so this idea of using this template
sounds good when there’s only one thing to pay attention to, so that in some ways is an urgent care
model.
Assistance from team D01: Certainly in my clinical flow, we could definitely address the time constraints, like having a
staff person ask these questions when somebody has a chief complaint of back pain and . . .it’s
new. . .
D27: A standardized approach. . . .we have a ton of templated things that our medical assistants fill
out at various frequencies with our patients before the physician or NP enters the room, so it
wouldn’t be difficult to implement.
Awareness Education D22: . . .we just need to realize that. . .this is one possibility of pain that is there, so we first of all
have to keep this in mind as one of the differential, sometimes we don’t.
D24: . . .I think awareness to this is important and . . ..any of those screening tools would be good
and, again, . . .being family medicine, most of what I get is through. . .one of the journals that we
use.
UpToDate/ journals/ conferences D22: I would say for 90% of my patients that I’m not really sure what’s going on with them
. . .before I go to see the patient, I almost always open UpToDate. For example, the patient is
coming in with something unusual that I haven’t seen before, I would just go to UpToDate, go to
the summary and recommendation center part of UpToDate and just read that, a little bit about
symptoms, a little bit about treatment.
Data driven D17: Well, I think evidence is always helpful . . ..data supporting that incorporating a specific
question set, screening questions, into your practice improves outcomes in some way, or increases
diagnosis of these inflammatory causes of back pain. I think that kind of stuff is convincing to
people. It’s always nice to have data to support your clinical practices, and I think . . .it’s just kind of
a reminder when you see something pop in Journal Watch or something, . . .that you should be
incorporating it, and you should adjust your practice if you’re not already using a tool like this and
one that is data driven.
US Preventive Task Force D31: And that screening guideline is going to be most likely best employed if you do it through the
United States Preventative Service Taskforce.
https://doi.org/10.1371/journal.pone.0252018.t006
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US Preventive Task Force before making recommendations for screening in primary care
practices [34]. This process begins with nominating a topic. If selected for further consider-
ation, the process would involve development of a research plan and review of published evi-
dence, culminating in a final recommendation statement.
In our study, physicians remarked that back pain tends to be a ‘doorknob’ question–one
that is left to the end of the visit when time already has run out. Short appointment times
impede a physician’s ability to fully explore the underlying reasons for back pain [30]. Patients
experiencing waxing and waning symptoms may be misidentified as experiencing new onset
back pain.
Participants in our study recommended various approaches using technology to assist with
axSpA screening. Incorporating axSpA screening questions into EMRs has been suggested as
being useful to improve efficiency in physicians’ offices [35]. Such an approach has encouraged
physician adherence to following recommended screening guidelines and has been successful
in some [36, 37], but not all, case studies [38]. Approaches that engage non-clinician support
staff [39] or employ automated tools improved screening in primary care settings [40].
Patient reported screening approaches (e.g., via online screening or an app) offer an alter-
native to EMR-based algorithms. Use of a non-invasive, algorithm to find cases of axSpA,
based on information contained in the EMR, has been studied using a randomized controlled
cluster trial design [41]. In the intervention arm, the diagnosis of axSpA was ultimately con-
firmed in 8% of subjects but this approach did not have a short term impact on physical func-
tion, as average disability scores were similar in both arms at 4 months [41].
Strengths/Limitations
The qualitative study design is a strength, as this approach often provides insights that cannot
be obtained by asking more closed-ended quantitative research questions. Our protocol
adhered to best practices for qualitative research. Despite that a convenience sample was used
[42] and some participants recruited were known to the researchers practicing medicine in
Massachusetts and Rhode Island, the primary interviewer (KLL) was not someone with a prior
relationship with the participants and therefore the interpretation bias could be reduced.
Despite that none of the physicians recalled ever having diagnosed a patient with axSpA, most
were confident in distinguishing inflammatory versus mechanical back pain. In addition, the
average years in practice was 15.7 years and the majority were affiliated with academic institu-
tions. Although primary care practices in the Northeast may differ from those in other regions
of the United States, the findings do not appear to be overly optimistic with respect to the
approach of screening for early detection of axSpA. None recalled ever having diagnosed a
patient with axSpA, although several reported having treated patients with ankylosing spondy-
litis that was diagnosed before coming under their care.
Conclusions
Primary care physicians believed that the delay in diagnosis of axSpA is too long. With respect
to the ASAS screening questions, physicians agreed that these questions need improvement
and noted that some questions were neither sensitive nor specific. Primary care physicians pre-
ferred a screening tool that recommends additional testing, rather than one that directs referral
to a rheumatologist. They believed that there may be a role for use of such a screening tool in
the primary care setting but requested evidence to support its implementation, since they
already must follow many other recommendations to screen for conditions more common
than axSpA. Strategies to implement axSpA screening must be mindful of practice workflow
issues and should be effective in reducing delay in diagnosis of axSpA.
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